JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lynch, J. W.
Right arrow Articles by Schofield, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lynch, J. W.
Right arrow Articles by Schofield, P. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 23, Issue of June 9, pp. 13799-13806, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Mutations Affecting the Glycine Receptor Agonist Transduction Mechanism Convert the Competitive Antagonist, Picrotoxin, into an Allosteric Potentiator

Joseph W. Lynch , Sundran Rajendra , Peter H. Barry , Peter R. Schofield

Contrary to its effects on the -aminobutyric acid type A receptor, picrotoxin antagonism of the 1 subunit of the human glycine receptor is shown to be competitive, not use-dependent, and nonselective between the picrotoxin components, picrotin, and picrotoxinin. Competitive antagonism and non-use dependence are consistent with picrotoxin binding to a site in the extracellular domain. The mutations Arg Leu or Arg Gln at residue 271 of the glycine receptor 1 subunit, which are both associated with human startle disease, have previously been demonstrated to disrupt the transduction process between agonist binding and channel activation. We show here that these mutations also transform picrotoxin from an allosterically acting competitive antagonist to an allosteric potentiator at low (0.01-3 µM) concentrations and to a noncompetitive antagonist at higher (3 µM) concentrations. This demonstrates that arginine 271 is involved in the transduction process between picrotoxin binding and its mechanism of action. Thus, the allosteric transduction pathways of both agonists and antagonists converge at a common residue prior to the activation gate of the channel, suggesting that this residue may act as an integration point for information from various extracellular ligand binding sites.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D.-S. Wang, R. Buckinx, H. Lecorronc, J.-M. Mangin, J.-M. Rigo, and P. Legendre
Mechanisms for Picrotoxinin and Picrotin Blocks of {alpha}2 Homomeric Glycine Receptors
J. Biol. Chem., June 1, 2007; 282(22): 16016 - 16035.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Sedelnikova, B. E. Erkkila, H. Harris, S. O. Zakharkin, and D. S. Weiss
Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor
J. Physiol., December 1, 2006; 577(2): 569 - 577.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-S. Wang, J.-M. Mangin, G. Moonen, J.-M. Rigo, and P. Legendre
Mechanisms for Picrotoxin Block of {alpha}2 Homomeric Glycine Receptors
J. Biol. Chem., February 17, 2006; 281(7): 3841 - 3855.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Hawthorne and J. W. Lynch
A Picrotoxin-specific Conformational Change in the Glycine Receptor M2-M3 Loop
J. Biol. Chem., October 28, 2005; 280(43): 35836 - 35843.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-M. Mangin, L. Nguyen, C. Gougnard, G. Hans, B. Rogister, S. Belachew, G. Moonen, P. Legendre, and J.-M. Rigo
Developmental Regulation of {beta}-Carboline-Induced Inhibition of Glycine-Evoked Responses Depends on Glycine Receptor {beta} Subunit Expression
Mol. Pharmacol., May 1, 2005; 67(5): 1783 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Qian, Y. Pan, Y. Zhu, and P. Khalili
Picrotoxin Accelerates Relaxation of GABAC Receptors
Mol. Pharmacol., February 1, 2005; 67(2): 470 - 479.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. W. Lynch
Molecular Structure and Function of the Glycine Receptor Chloride Channel
Physiol Rev, October 1, 2004; 84(4): 1051 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
N. L. Absalom, T. M. Lewis, and P. R. Schofield
Mechanisms of channel gating of the ligand-gated ion channel superfamily inferred from protein structure
Exp Physiol, March 1, 2004; 89(2): 145 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. L. Thio, A. Shanmugam, K. Isenberg, and K. Yamada
Benzodiazepines Block {alpha}2-Containing Inhibitory Glycine Receptors in Embryonic Mouse Hippocampal Neurons
J Neurophysiol, July 1, 2003; 90(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
P. Tang, P. K. Mandal, and Y. Xu
NMR Structures of the Second Transmembrane Domain of the Human Glycine Receptor alpha 1 Subunit: Model of Pore Architecture and Channel Gating
Biophys. J., July 1, 2002; 83(1): 252 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. I. Dibas, E. B. Gonzales, P. Das, C. L. Bell-Horner, and G. H. Dillon
Identification of a Novel Residue within the Second Transmembrane Domain That Confers Use-facilitated Block by Picrotoxin in Glycine alpha 1 Receptors
J. Biol. Chem., March 8, 2002; 277(11): 9112 - 9117.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R.-Q. Huang, C. L. Bell-Horner, M. I. Dibas, D. F. Covey, J. A. Drewe, and G. H. Dillon
Pentylenetetrazole-Induced Inhibition of Recombinant gamma -Aminobutyric Acid Type A (GABAA) Receptors: Mechanism and Site of Action
J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 986 - 995.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J. W. Lynch, N.-L. R. Han, J. Haddrill, K. D. Pierce, and P. R. Schofield
The Surface Accessibility of the Glycine Receptor M2-M3 Loop Is Increased in the Channel Open State
J. Neurosci., April 15, 2001; 21(8): 2589 - 2599.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. H. Steinbach, J. Bracamontes, L. Yu, P. Zhang, and D. F. Covey
Subunit-Specific Action of an Anticonvulsant Thiobutyrolactone on Recombinant Glycine Receptors Involves a Residue in the M2 Membrane-Spanning Region
Mol. Pharmacol., July 1, 2000; 58(1): 11 - 17.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
S. Levi, D. Chesnoy-Marchais, W. Sieghart, and A. Triller
Synaptic Control of Glycine and GABAA Receptors and Gephyrin Expression in Cultured Motoneurons
J. Neurosci., September 1, 1999; 19(17): 7434 - 7449.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Moorhouse, P. Jacques, P. H. Barry, and P. R. Schofield
The Startle Disease Mutation Q266H, in the Second Transmembrane Domain of the Human Glycine Receptor, Impairs Channel Gating
Mol. Pharmacol., February 1, 1999; 55(2): 386 - 395.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
A. Stumpner
Picrotoxin Eliminates Frequency Selectivity of an Auditory Interneuron in a Bushcricket
J Neurophysiol, May 1, 1998; 79(5): 2408 - 2415.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. Legendre
Pharmacological Evidence for Two Types of Postsynaptic Glycinergic Receptors on the Mauthner Cell of 52-h-Old Zebrafish Larvae
J Neurophysiol, May 1, 1997; 77(5): 2400 - 2415.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Ueno, J. Bracamontes, C. Zorumski, D. S. Weiss, and J. H. Steinbach
Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor
J. Neurosci., January 15, 1997; 17(2): 625 - 634.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Shan, J. L. Haddrill, and J. W. Lynch
Ivermectin, an Unconventional Agonist of the Glycine Receptor Chloride Channel
J. Biol. Chem., April 13, 2001; 276(16): 12556 - 12564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.